Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-1-5
pubmed:abstractText
One form of the hereditary long-QT syndrome, LQT3-Delta KPQ, is associated with sustained inward sodium current during membrane depolarization. Ranolazine reduces late sodium channel current, and we hypothesized that ranolazine would have beneficial effects on electrical and mechanical cardiac function in LQT3 patients with the SCN5A-DeltaKPQ mutation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-10381892, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-11333173, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-12379577, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-15031300, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-15243300, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-15277312, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-15302796, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-15378132, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-16274417, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-16376782, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-16520744, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-16565163, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-17698727, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-17804441, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-18662183, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-1884444, http://linkedlifedata.com/resource/pubmed/commentcorrection/18662191-7651517
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1540-8167
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1289-93
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:18662191-Acetanilides, pubmed-meshheading:18662191-Adolescent, pubmed-meshheading:18662191-Adult, pubmed-meshheading:18662191-Electrocardiography, pubmed-meshheading:18662191-Enzyme Inhibitors, pubmed-meshheading:18662191-Female, pubmed-meshheading:18662191-Genetic Predisposition to Disease, pubmed-meshheading:18662191-Heart Conduction System, pubmed-meshheading:18662191-Heart Rate, pubmed-meshheading:18662191-Humans, pubmed-meshheading:18662191-Long QT Syndrome, pubmed-meshheading:18662191-Male, pubmed-meshheading:18662191-Middle Aged, pubmed-meshheading:18662191-Muscle Proteins, pubmed-meshheading:18662191-Piperazines, pubmed-meshheading:18662191-Sodium, pubmed-meshheading:18662191-Sodium Channels, pubmed-meshheading:18662191-Treatment Outcome, pubmed-meshheading:18662191-Young Adult
pubmed:year
2008
pubmed:articleTitle
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.
pubmed:affiliation
Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642-8653, USA. heartajm@heart.rochester.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural